← brief for 2026-10-16 · Slowing decline

GLP-1 receptor agonist use and contrast-associated acute kidney injury after contrast-enhanced CT and CT angiography in adults with type 2 diabetes and chronic kidney disease: a propensity score-matched cohort study.

Article C Peer reviewed Observational

Key takeaways

This study looked at people with diabetes and kidney disease who had CT scans. It checked if using GLP-1 drugs was linked to kidney injury from the scan dye. The results show a link, but they do not prove the drug caused the injury. More research is needed to confirm safety.

Who did this work

Chang Y · Chi KY · Lin HM

Source

Article · PubMed, the drug frontier · 2026 Oct 16
https://pubmed.ncbi.nlm.nih.gov/42886239/